These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11727350)

  • 1. Rational prescribing of statins.
    Purcell H; Daly C; Sheppard M; Morrell J
    Practitioner; 2001 Nov; 245(1628):957-9, 962-3. PubMed ID: 11727350
    [No Abstract]   [Full Text] [Related]  

  • 2. [Few patients with coronary diseases are receiving lipid-lowering therapy].
    Stagmo M; Hofman-Bang C; Erhardt L; Rydén L
    Lakartidningen; 2002 Apr; 99(16):1798-9, 1802-3. PubMed ID: 12043479
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of determining serum cholesterol levels in patients with coronary heart disease].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2545-8. PubMed ID: 9555153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic influence on the blood lipids in manifest coronary sclerosis].
    Aschenbeck G
    Rev Bras Med; 1971 Dec; 28(12):653-8. PubMed ID: 4259647
    [No Abstract]   [Full Text] [Related]  

  • 5. Barriers to the use of statins.
    Penston J
    Br J Gen Pract; 2003 Nov; 53(496):886; author reply 887. PubMed ID: 14702911
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical implications of clinical studies: can we compare different subgroups defined a posteriori?
    Vohnout B
    Eur Heart J; 2001 May; 22(9):798. PubMed ID: 11350113
    [No Abstract]   [Full Text] [Related]  

  • 7. [Considerable remaining risk in unchecked LDL lowering. Is the HDL increase the way out?].
    MMW Fortschr Med; 2006 Jun; 148(24):6, 8. PubMed ID: 16856232
    [No Abstract]   [Full Text] [Related]  

  • 8. [MMW- Drug Prize 2005 for simvastatin/ezetimib (Inegy). LDL goal values are easier to reach now].
    Füessl HS
    MMW Fortschr Med; 2005 Oct; 147(43):13. PubMed ID: 16302413
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence.
    Preiss D; Sattar N
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):815-28. PubMed ID: 19067719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use over time of statins in coronary patients in an Italian tertiary referral center.
    Gaspardone A; Proietti I; Altamura L; Tomai F; Versaci F; Crea F; Chiariello L; Gioffrè PA
    Ital Heart J; 2001 Nov; 2(11):848-53. PubMed ID: 11770871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to the use of statins.
    Kemple T
    Br J Gen Pract; 2003 Nov; 53(496):886-7; author reply 887. PubMed ID: 14702912
    [No Abstract]   [Full Text] [Related]  

  • 13. Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001.
    Tonstad S; Rosvold EO; Furu K; Skurtveit S
    J Intern Med; 2004 Apr; 255(4):494-502. PubMed ID: 15049884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What do the statins tell us?
    LaRosa JC
    Am Heart J; 2002 Dec; 144(6 Suppl):S21-6. PubMed ID: 12486412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving prescribing practices in primary care. A randomised trial and economic analysis of a multicomponent intervention showed small, but important, gains.
    Del Mar C
    PLoS Med; 2006 Jun; 3(6):e229. PubMed ID: 16729845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of coronary artery disease as a result of intensive lipid-lowering therapy.
    N Engl J Med; 1991 Apr; 324(16):1133-5. PubMed ID: 2008188
    [No Abstract]   [Full Text] [Related]  

  • 17. The cholesterol hypothesis: questioned?
    Somberg JC; Molnar J
    Am J Ther; 2008; 15(3):292-5. PubMed ID: 18496268
    [No Abstract]   [Full Text] [Related]  

  • 18. [Statin therapy is a basic treatment for coronary heart disease].
    Gurevich MA
    Klin Med (Mosk); 2003; 81(12):60-2. PubMed ID: 14971160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vasoprotective effects of statins and angiotensin II blockers in atherothrombosis].
    Egido J; Ruiz-Ortega M; Muñoz-García B; Martín-Ventura JL; Blanco-Colio LM
    Nefrologia; 2005; 25 Suppl 2():117-28. PubMed ID: 16050414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The action of 1,4-dicaffeylquinic acid on the lipid fractions of the blood in atherosclerosis].
    Caruzzo C; Carnaghi R; Enrico-Bena L; De Marco G
    Minerva Med; 1969 Nov; 60(91):4514-8. PubMed ID: 5357297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.